179 related articles for article (PubMed ID: 30862962)
21. TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia.
Sakoda T; Kikushige Y; Miyamoto T; Irifune H; Harada T; Hatakeyama K; Kunisaki Y; Kato K; Akashi K
Blood Adv; 2023 May; 7(10):2053-2065. PubMed ID: 36745103
[TBL] [Abstract][Full Text] [Related]
22. Tetraspanin CD82 Regulates the Spatiotemporal Dynamics of PKCα in Acute Myeloid Leukemia.
Termini CM; Lidke KA; Gillette JM
Sci Rep; 2016 Jul; 6():29859. PubMed ID: 27417454
[TBL] [Abstract][Full Text] [Related]
23. miRNA-222-3p enhances the proliferation and suppresses the apoptosis of acute myeloid leukemia cells by targeting Axin2 and modulating the Wnt/β-catenin pathway.
Liu Z; Zhong L; Dan W; Chu X; Liu C; Luo X; Zhang Z; Lu Y; Wan P; Wang X; Liu B
Biochem Biophys Res Commun; 2022 Sep; 620():83-91. PubMed ID: 35780585
[TBL] [Abstract][Full Text] [Related]
24. LncRNA LINC00909 promotes cell proliferation and metastasis in pediatric acute myeloid leukemia via miR-625-mediated modulation of Wnt/β-catenin signaling.
Ma L; Wang YY; Jiang P
Biochem Biophys Res Commun; 2020 Jun; 527(3):654-661. PubMed ID: 32423818
[TBL] [Abstract][Full Text] [Related]
25. Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherin.
Marjon KD; Termini CM; Karlen KL; Saito-Reis C; Soria CE; Lidke KA; Gillette JM
Oncogene; 2016 Aug; 35(31):4132-40. PubMed ID: 26592446
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.
Sadras T; Perugini M; Kok CH; Iarossi DG; Heatley SL; Brumatti G; Samuel MS; To LB; Lewis ID; Lopez AF; Ekert PG; Ramshaw HS; D'Andrea RJ
J Leukoc Biol; 2014 Jul; 96(1):83-91. PubMed ID: 24598054
[TBL] [Abstract][Full Text] [Related]
27. Propofol inhibits biological functions of leukaemia stem and differentiated cells through suppressing Wnt/β-catenin and Akt/mTOR.
Chen L; Wan Y; Liu Y; Li T
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):127-134. PubMed ID: 31429973
[TBL] [Abstract][Full Text] [Related]
28. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
29. SOX30 confers a tumor suppressive effect in acute myeloid leukemia through inactivation of Wnt/β-catenin signaling.
Liu Y; Wang W; Li Y; Huang Y
Mol Cell Probes; 2020 Aug; 52():101578. PubMed ID: 32334007
[TBL] [Abstract][Full Text] [Related]
30. Regeneration-associated WNT signaling is activated in long-term reconstituting AC133bright acute myeloid leukemia cells.
Beghini A; Corlazzoli F; Del Giacco L; Re M; Lazzaroni F; Brioschi M; Valentini G; Ferrazzi F; Ghilardi A; Righi M; Turrini M; Mignardi M; Cesana C; Bronte V; Nilsson M; Morra E; Cairoli R
Neoplasia; 2012 Dec; 14(12):1236-48. PubMed ID: 23308055
[TBL] [Abstract][Full Text] [Related]
31. EZH2 mediates ATO-induced apoptosis in acute myeloid leukemia cell lines through the Wnt signaling pathway.
Zhang H; Gu H; Li L; Ren Y; Zhang L
Tumour Biol; 2016 May; 37(5):5919-23. PubMed ID: 26592252
[TBL] [Abstract][Full Text] [Related]
32. HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.
Yang S; Gu Y; Wang G; Hu Q; Chen S; Wang Y; Zhao M
Int J Mol Med; 2019 Aug; 44(2):427-436. PubMed ID: 31173171
[TBL] [Abstract][Full Text] [Related]
33. GPR84 sustains aberrant β-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis.
Dietrich PA; Yang C; Leung HH; Lynch JR; Gonzales E; Liu B; Haber M; Norris MD; Wang J; Wang JY
Blood; 2014 Nov; 124(22):3284-94. PubMed ID: 25293777
[TBL] [Abstract][Full Text] [Related]
34. MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism.
Ueda K; Kumari R; Schwenger E; Wheat JC; Bohorquez O; Narayanagari SR; Taylor SJ; Carvajal LA; Pradhan K; Bartholdy B; Todorova TI; Goto H; Sun D; Chen J; Shan J; Song Y; Montagna C; Xiong S; Lozano G; Pellagatti A; Boultwood J; Verma A; Steidl U
Cancer Cell; 2021 Apr; 39(4):529-547.e7. PubMed ID: 33667384
[TBL] [Abstract][Full Text] [Related]
35. N-glycosylation of CD82 at Asn157 is required for suppressing migration and invasion by reversing EMT via Wnt/β-catenin pathway in colon cancer.
Zhu L; Chen Y; Du H; Cong Y; Yan W; Ma K; Huang X
Biochem Biophys Res Commun; 2022 Nov; 629():121-127. PubMed ID: 36116374
[TBL] [Abstract][Full Text] [Related]
36. [Expressions of CDX2 and β-catenin and their correlation in acute myeloid leukemia].
Wang W; Meng C; Liu J; Yang Z
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):728-32. PubMed ID: 26018272
[TBL] [Abstract][Full Text] [Related]
37. An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML.
Carter BZ; Mak PY; Wang X; Tao W; Ruvolo V; Mak D; Mu H; Burks JK; Andreeff M
Cancer Res; 2019 Mar; 79(6):1165-1177. PubMed ID: 30674535
[TBL] [Abstract][Full Text] [Related]
38. Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis.
Ysebaert L; Chicanne G; Demur C; De Toni F; Prade-Houdellier N; Ruidavets JB; Mansat-De Mas V; Rigal-Huguet F; Laurent G; Payrastre B; Manenti S; Racaud-Sultan C
Leukemia; 2006 Jul; 20(7):1211-6. PubMed ID: 16688229
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological targeting of type phosphodiesterase 4 inhibits the development of acute myeloid leukemia by impairing mitochondrial function through the Wnt/β-catenin pathway.
Mao P; Huang C; Li Y; Zhao Y; Zhou S; Zhao Z; Mu Y; Wang L; Li F; Zhao AZ
Biomed Pharmacother; 2023 Jan; 157():114027. PubMed ID: 36436494
[TBL] [Abstract][Full Text] [Related]
40. Expression and role of fibroblast activation protein α in acute myeloid leukemia.
Mei S; Zhang Y; Yu L; Chen G; Zi F
Oncol Rep; 2021 Feb; 45(2):641-651. PubMed ID: 33416165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]